AXGN Q1 2023 Earnings — AxoGen, Inc. Revenue & Financial Results | Market Cap Arena

AXGNAxoGen, Inc.

$2B

Q1 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$37M+18.2% YoY

Gross Profit

$30M81.7% margin

Operating Income

-$7M-20.0% margin

Net Income

-$7M-19.3% margin

EPS (Diluted)

$-0.17

QoQ Revenue Growth

+1.4%

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

-$12M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$189M

Total Liabilities

$92M

Stockholders' Equity

$98M

Cash & Equivalents

$14M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$37M	$31M	+18.2%
Gross Profit	$30M	$25M	+17.7%
Operating Income	-$7M	-$11M	+35.2%
Net Income	-$7M	-$11M	+38.4%